Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tweet, Tweet, Tweet: Pharma Finding Its Niche?

Executive Summary

The industry has been slow to adopt new technologies in the highly regulated pharma world, but both big and small biopharmas alike are beginning to find their comfort zone with limited-character media like Twitter.

Advertisement

Related Content

Hemophilia Market Snapshot: Is There Enough Innovation For Patients To Switch?
Social Media Marketing: FDA’s Old-Time Approach May Turn Industry Away
FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
Biogen Idec Undercuts Gilenya With $55,000 Yearly Price For Tecfidera

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS056303

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel